active ras detection kit Search Results


95
Cytoskeleton Inc activation assay biochem kit
Activation Assay Biochem Kit, supplied by Cytoskeleton Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/active+ras+detection+kit/Ras+Pull-down+Activation+Assay+Biochem+Kit/pmc13132366-287-3-7
Average 95 stars, based on 1 article reviews
activation assay biochem kit - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

95
Cytoskeleton Inc ras activity
Ras Activity, supplied by Cytoskeleton Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/active+ras+detection+kit/Ras+G-LISA+GTPase+Activation+Assay+Kit/pm24356578-60-4-21
Average 95 stars, based on 1 article reviews
ras activity - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

95
Cell Signaling Technology Inc active ras detection kit
Active Ras Detection Kit, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/active+ras+detection+kit/Active+Ras+Detection+Kit/pmc04922698-587-17-21
Average 95 stars, based on 1 article reviews
active ras detection kit - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

90
Upstate Biotechnology Inc cdc42 activation kit
Cdc42 Activation Kit, supplied by Upstate Biotechnology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/active+ras+detection+kit/ras+activation+assay+kit/pm12928366-71-8-12
Average 90 stars, based on 1 article reviews
cdc42 activation kit - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Upstate Biotechnology Inc ras and rac activation assay kit
Ras And Rac Activation Assay Kit, supplied by Upstate Biotechnology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/active+ras+detection+kit/ras+and+rac+activation+assay+kit/pm11943210-33-9-15
Average 90 stars, based on 1 article reviews
ras and rac activation assay kit - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Upstate Biotechnology Inc ras activation kit
Ras Activation Kit, supplied by Upstate Biotechnology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/active+ras+detection+kit/ras+activation+kit/10__1074_slash_jbc__m009099200-129-8-11
Average 90 stars, based on 1 article reviews
ras activation kit - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
NewEast Biosciences ras activation assay kit #81101
Ras Activation Assay Kit #81101, supplied by NewEast Biosciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/active+ras+detection+kit/ras+activation+assay+kit/pmc06726755-288-9-13
Average 90 stars, based on 1 article reviews
ras activation assay kit #81101 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
EntroGen Inc rt-pcr ras c.59/117 mutation detection kit
Rt Pcr Ras C.59/117 Mutation Detection Kit, supplied by EntroGen Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/active+ras+detection+kit/rt+pcr+ras+c+59+117+mutation+detection+kit/pmc06137366-97-20-26
Average 90 stars, based on 1 article reviews
rt-pcr ras c.59/117 mutation detection kit - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Cell Biolabs Inc k-ras activation assay kit
K Ras Activation Assay Kit, supplied by Cell Biolabs Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/active+ras+detection+kit/pan+ras+activation+assay+kit/pmc05377463-198-10-14
Average 90 stars, based on 1 article reviews
k-ras activation assay kit - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Upstate Group Inc ras activation assay kit
Nef-induced <t>Ras-Raf-MAPK1,2</t> <t>activation</t> in podocytes. Nef-infected podocytes (Nef) and control podocytes (V) were prepared as previously described. Phospho–c-Raf and phospho-MAPK1,2 (p-MAPK1,2) were detected by Western blot using specific antibodies. Ras-GTP was determined by a pull-down <t>assay</t> using Raf1-RBD as the trap. Densitometric data: Ras-GTP: V = 17 ± 4.5, Nef = 49 ± 7.4, P < 0.05, n = 3; c-Raf: V = 0.93 ± 0.25, Nef = 2.74 ± 0.45, P < 0.05, n = 3; phospho-MAPK1,2/total MAPK1,2 ratio: V = 0.37 ± 0.05, Nef = 0.65 ± 0.10, P < 0.01, n = 5.
Ras Activation Assay Kit, supplied by Upstate Group Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/active+ras+detection+kit/ras+activation+assay+kit/pmc00514582-404-6-10
Average 90 stars, based on 1 article reviews
ras activation assay kit - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Riken Genesis Co Ltd kras kit forward primer
Oligonucleotides used in this study
Kras Kit Forward Primer, supplied by Riken Genesis Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/active+ras+detection+kit/bna+real+time+pcr+mutation+detection+kit+extended+ras/pmc09154250-8-0-15
Average 90 stars, based on 1 article reviews
kras kit forward primer - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Merck KGaA ras activation assay kit
Transformation of porcine MSCs. ( a ) Overview of stepwise transformation of genetically modified porcine MSCs. ( b ) Left: Cre-mediated excision of transcriptional termination cassette from the KRAS LSL-G12D allele. Cell types as shown. PCR amplification products across the site of the LSL-BS cassette in KRAS intron 1. Predicted fragment sizes: wild-type KRAS 167 bp; non-recombined KRAS LSL-G12D 1486 bp; Cre-excised KRAS L-G12D 201 bp. Right: Cre-mediated excision of transcriptional termination cassette from both TP53 LSL-R167H alleles. Cell types as shown. PCR amplification products across the site of LSL-NEO cassette in TP53 intron 1. Predicted fragment sizes: wild-type TP53 198 bp; non-recombined TP53 LSL-R167H 1929 bp; Cre-excised TP53 L-R167H 254 bp. ( c ) <t>Ras</t> <t>activation</t> <t>assay</t> and p53 western blotting analysis. Cre-recombined MSC-PKC and MSC-PKCM cells show increased levels of active GTP-bound Ras proteins (21 kDa) as well as abundant levels of mutant p53-R167H proteins (46 kDa). ( d ) EdU (5-ethynyl-2'-deoxyuridine) incorporation during S phase. Data are consistent with the enhanced proliferative capacity of genetically modified derivatives relative to wild-type MSCs. P -values: MSC-PK=0.0727; MSC-PKC=0.0042; MSC-PKCM=0.0019. ( e ) Upper row: Loss of contact inhibition. MSC-PKCM cells form multi-layered foci when cultured at higher densities. Scale bars indicate 400 μm. Lower row: Anchorage-independent growth in soft agar. Wild-type MSCs grow as single cells in semi-solid medium, whereas MSC-PK, MSC-PKC and MSC-PKCM cells form three-dimensional colonies. Scale bars indicate 400 μm. ( f ) Upper: H&E-stained section of paucicellular nodule formed by injected MSC-PKC cells. The nodule consists mainly of matrigel with fat islands, capillary sprouts and isolated cells with slightly irregular nuclei. Scale bar indicates 500 μm. The arrow indicates an area of higher cellularity. Lower: Mesenchymal cells with slightly irregular nuclei embedded in a myxoid stroma are evident at higher magnification. Scale bar indicates 100 μm. ( g ) H&E-stained sections of MSC-PKCM derived tumour. This tumour is mostly highly cellular, but a matrix-rich area is still present, for example, as indicated by an asterisk. In the cellular areas, large tumour cells with pleomorphic nuclei are evident. A chronic inflammatory reaction is also present. Scale bar indicates 200 μm.
Ras Activation Assay Kit, supplied by Merck KGaA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/active+ras+detection+kit/ras+activation+elisa+assay+kit/pmc04815050-195-6-10
Average 90 stars, based on 1 article reviews
ras activation assay kit - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

Image Search Results


Nef-induced Ras-Raf-MAPK1,2 activation in podocytes. Nef-infected podocytes (Nef) and control podocytes (V) were prepared as previously described. Phospho–c-Raf and phospho-MAPK1,2 (p-MAPK1,2) were detected by Western blot using specific antibodies. Ras-GTP was determined by a pull-down assay using Raf1-RBD as the trap. Densitometric data: Ras-GTP: V = 17 ± 4.5, Nef = 49 ± 7.4, P < 0.05, n = 3; c-Raf: V = 0.93 ± 0.25, Nef = 2.74 ± 0.45, P < 0.05, n = 3; phospho-MAPK1,2/total MAPK1,2 ratio: V = 0.37 ± 0.05, Nef = 0.65 ± 0.10, P < 0.01, n = 5.

Journal:

Article Title: Nef stimulates proliferation of glomerular podocytes through activation of Src-dependent Stat3 and MAPK1,2 pathways

doi: 10.1172/JCI200421004

Figure Lengend Snippet: Nef-induced Ras-Raf-MAPK1,2 activation in podocytes. Nef-infected podocytes (Nef) and control podocytes (V) were prepared as previously described. Phospho–c-Raf and phospho-MAPK1,2 (p-MAPK1,2) were detected by Western blot using specific antibodies. Ras-GTP was determined by a pull-down assay using Raf1-RBD as the trap. Densitometric data: Ras-GTP: V = 17 ± 4.5, Nef = 49 ± 7.4, P < 0.05, n = 3; c-Raf: V = 0.93 ± 0.25, Nef = 2.74 ± 0.45, P < 0.05, n = 3; phospho-MAPK1,2/total MAPK1,2 ratio: V = 0.37 ± 0.05, Nef = 0.65 ± 0.10, P < 0.01, n = 5.

Article Snippet: Ras activity was measured using a Ras Activation Assay Kit (Upstate Group Inc.).

Techniques: Activation Assay, Infection, Control, Western Blot, Pull Down Assay

Oligonucleotides used in this study

Journal: Biology Methods & Protocols

Article Title: Cationic copolymers that enhance wild-type-specific suppression in BNA-clamp PCR and preferentially increase the T m of fully matched complementary DNA and BNA strands

doi: 10.1093/biomethods/bpac009

Figure Lengend Snippet: Oligonucleotides used in this study

Article Snippet: KRAS kit forward primer , CTGAATATAAACTTGTGGTAGTTGG , 25 , DNA , BNA clamp PCR , Riken Genesis Inc..

Techniques: Sequencing, Real-time Polymerase Chain Reaction

Representative melting curve profiles of the 40-mer oligonucleotides encoding a part of the KRAS gene. ( A ) Fluorescence intensity plot and ( B ) derivative plots corresponding to the addition of buffer control (i.e. no polymers), 1.5 mM MgCl 2 , 1% (w/v) P1, 1% (w/v) P2. Note that P1 showed a significantly lower fluorescence intensity below 58°C where the DNA duplex is formed even without MgCl 2 , indicating disruption of the DNA duplex.

Journal: Biology Methods & Protocols

Article Title: Cationic copolymers that enhance wild-type-specific suppression in BNA-clamp PCR and preferentially increase the T m of fully matched complementary DNA and BNA strands

doi: 10.1093/biomethods/bpac009

Figure Lengend Snippet: Representative melting curve profiles of the 40-mer oligonucleotides encoding a part of the KRAS gene. ( A ) Fluorescence intensity plot and ( B ) derivative plots corresponding to the addition of buffer control (i.e. no polymers), 1.5 mM MgCl 2 , 1% (w/v) P1, 1% (w/v) P2. Note that P1 showed a significantly lower fluorescence intensity below 58°C where the DNA duplex is formed even without MgCl 2 , indicating disruption of the DNA duplex.

Article Snippet: KRAS kit forward primer , CTGAATATAAACTTGTGGTAGTTGG , 25 , DNA , BNA clamp PCR , Riken Genesis Inc..

Techniques: Fluorescence, Control, Disruption

Representative real-time PCR amplification plot of KRAS gene amplification. The KRAS wild-type was amplified from genomic DNA (1.65 × 10 4 copies per reaction) in an TB Green intercalating real-time PCR system in the presence of buffer control (i.e. no polymers) , P10 (slight inhibition), P11 (complete inhibition), and P12 (no inhibition). In this example, the final concentrations of all polymers in the reaction mixtures were 0.01% (w/v).

Journal: Biology Methods & Protocols

Article Title: Cationic copolymers that enhance wild-type-specific suppression in BNA-clamp PCR and preferentially increase the T m of fully matched complementary DNA and BNA strands

doi: 10.1093/biomethods/bpac009

Figure Lengend Snippet: Representative real-time PCR amplification plot of KRAS gene amplification. The KRAS wild-type was amplified from genomic DNA (1.65 × 10 4 copies per reaction) in an TB Green intercalating real-time PCR system in the presence of buffer control (i.e. no polymers) , P10 (slight inhibition), P11 (complete inhibition), and P12 (no inhibition). In this example, the final concentrations of all polymers in the reaction mixtures were 0.01% (w/v).

Article Snippet: KRAS kit forward primer , CTGAATATAAACTTGTGGTAGTTGG , 25 , DNA , BNA clamp PCR , Riken Genesis Inc..

Techniques: Real-time Polymerase Chain Reaction, Amplification, Control, Inhibition

Effects of representative copolymers (P17) on wild-type-specific suppression in BNA-clamp PCR to detect KRAS G13D mutation from genomic DNA. ( A ) Real-time PCR to amplify the KRAS gene encompassing the G13 codon was performed with genomic DNA templates (1.65 × 10 4 copies per reaction) of wild-type cells (HCC70) and mutant cells (MDA-MB-231) in the presence and absence of the BNA clamp and 0.025% (w/v) P17 polymer. ( B ) While keeping the total amount of the genomic DNA template at 1.65 × 10 4 copies per reaction, the proportion of DNA from the mutant cells was incrementally decreased to 1%, 0.1%, 0.01%, and 0% (i.e. 100% wild-type as a reference). The BNA clamp was included in both reactions. ( C ) Direct sequencing of PCR products from the reaction shown in B at 1%, 0.1%, and 0.01% mutant-to-wild-type ratio.

Journal: Biology Methods & Protocols

Article Title: Cationic copolymers that enhance wild-type-specific suppression in BNA-clamp PCR and preferentially increase the T m of fully matched complementary DNA and BNA strands

doi: 10.1093/biomethods/bpac009

Figure Lengend Snippet: Effects of representative copolymers (P17) on wild-type-specific suppression in BNA-clamp PCR to detect KRAS G13D mutation from genomic DNA. ( A ) Real-time PCR to amplify the KRAS gene encompassing the G13 codon was performed with genomic DNA templates (1.65 × 10 4 copies per reaction) of wild-type cells (HCC70) and mutant cells (MDA-MB-231) in the presence and absence of the BNA clamp and 0.025% (w/v) P17 polymer. ( B ) While keeping the total amount of the genomic DNA template at 1.65 × 10 4 copies per reaction, the proportion of DNA from the mutant cells was incrementally decreased to 1%, 0.1%, 0.01%, and 0% (i.e. 100% wild-type as a reference). The BNA clamp was included in both reactions. ( C ) Direct sequencing of PCR products from the reaction shown in B at 1%, 0.1%, and 0.01% mutant-to-wild-type ratio.

Article Snippet: KRAS kit forward primer , CTGAATATAAACTTGTGGTAGTTGG , 25 , DNA , BNA clamp PCR , Riken Genesis Inc..

Techniques: Mutagenesis, Real-time Polymerase Chain Reaction, Polymer, Sequencing

Melting curve analysis of 11-mer complementary strands encompassing the KRAS G13D mutation site. ( A ) Profiles from DNA–DNA strands with a perfect match (wild-type) and a single nucleotide mismatch (mutant) with the addition of P12. ( B ) Profile from the DNA–BNA strands equivalent to (A).

Journal: Biology Methods & Protocols

Article Title: Cationic copolymers that enhance wild-type-specific suppression in BNA-clamp PCR and preferentially increase the T m of fully matched complementary DNA and BNA strands

doi: 10.1093/biomethods/bpac009

Figure Lengend Snippet: Melting curve analysis of 11-mer complementary strands encompassing the KRAS G13D mutation site. ( A ) Profiles from DNA–DNA strands with a perfect match (wild-type) and a single nucleotide mismatch (mutant) with the addition of P12. ( B ) Profile from the DNA–BNA strands equivalent to (A).

Article Snippet: KRAS kit forward primer , CTGAATATAAACTTGTGGTAGTTGG , 25 , DNA , BNA clamp PCR , Riken Genesis Inc..

Techniques: Mutagenesis

Transformation of porcine MSCs. ( a ) Overview of stepwise transformation of genetically modified porcine MSCs. ( b ) Left: Cre-mediated excision of transcriptional termination cassette from the KRAS LSL-G12D allele. Cell types as shown. PCR amplification products across the site of the LSL-BS cassette in KRAS intron 1. Predicted fragment sizes: wild-type KRAS 167 bp; non-recombined KRAS LSL-G12D 1486 bp; Cre-excised KRAS L-G12D 201 bp. Right: Cre-mediated excision of transcriptional termination cassette from both TP53 LSL-R167H alleles. Cell types as shown. PCR amplification products across the site of LSL-NEO cassette in TP53 intron 1. Predicted fragment sizes: wild-type TP53 198 bp; non-recombined TP53 LSL-R167H 1929 bp; Cre-excised TP53 L-R167H 254 bp. ( c ) Ras activation assay and p53 western blotting analysis. Cre-recombined MSC-PKC and MSC-PKCM cells show increased levels of active GTP-bound Ras proteins (21 kDa) as well as abundant levels of mutant p53-R167H proteins (46 kDa). ( d ) EdU (5-ethynyl-2'-deoxyuridine) incorporation during S phase. Data are consistent with the enhanced proliferative capacity of genetically modified derivatives relative to wild-type MSCs. P -values: MSC-PK=0.0727; MSC-PKC=0.0042; MSC-PKCM=0.0019. ( e ) Upper row: Loss of contact inhibition. MSC-PKCM cells form multi-layered foci when cultured at higher densities. Scale bars indicate 400 μm. Lower row: Anchorage-independent growth in soft agar. Wild-type MSCs grow as single cells in semi-solid medium, whereas MSC-PK, MSC-PKC and MSC-PKCM cells form three-dimensional colonies. Scale bars indicate 400 μm. ( f ) Upper: H&E-stained section of paucicellular nodule formed by injected MSC-PKC cells. The nodule consists mainly of matrigel with fat islands, capillary sprouts and isolated cells with slightly irregular nuclei. Scale bar indicates 500 μm. The arrow indicates an area of higher cellularity. Lower: Mesenchymal cells with slightly irregular nuclei embedded in a myxoid stroma are evident at higher magnification. Scale bar indicates 100 μm. ( g ) H&E-stained sections of MSC-PKCM derived tumour. This tumour is mostly highly cellular, but a matrix-rich area is still present, for example, as indicated by an asterisk. In the cellular areas, large tumour cells with pleomorphic nuclei are evident. A chronic inflammatory reaction is also present. Scale bar indicates 200 μm.

Journal: Oncogenesis

Article Title: A porcine model of osteosarcoma

doi: 10.1038/oncsis.2016.19

Figure Lengend Snippet: Transformation of porcine MSCs. ( a ) Overview of stepwise transformation of genetically modified porcine MSCs. ( b ) Left: Cre-mediated excision of transcriptional termination cassette from the KRAS LSL-G12D allele. Cell types as shown. PCR amplification products across the site of the LSL-BS cassette in KRAS intron 1. Predicted fragment sizes: wild-type KRAS 167 bp; non-recombined KRAS LSL-G12D 1486 bp; Cre-excised KRAS L-G12D 201 bp. Right: Cre-mediated excision of transcriptional termination cassette from both TP53 LSL-R167H alleles. Cell types as shown. PCR amplification products across the site of LSL-NEO cassette in TP53 intron 1. Predicted fragment sizes: wild-type TP53 198 bp; non-recombined TP53 LSL-R167H 1929 bp; Cre-excised TP53 L-R167H 254 bp. ( c ) Ras activation assay and p53 western blotting analysis. Cre-recombined MSC-PKC and MSC-PKCM cells show increased levels of active GTP-bound Ras proteins (21 kDa) as well as abundant levels of mutant p53-R167H proteins (46 kDa). ( d ) EdU (5-ethynyl-2'-deoxyuridine) incorporation during S phase. Data are consistent with the enhanced proliferative capacity of genetically modified derivatives relative to wild-type MSCs. P -values: MSC-PK=0.0727; MSC-PKC=0.0042; MSC-PKCM=0.0019. ( e ) Upper row: Loss of contact inhibition. MSC-PKCM cells form multi-layered foci when cultured at higher densities. Scale bars indicate 400 μm. Lower row: Anchorage-independent growth in soft agar. Wild-type MSCs grow as single cells in semi-solid medium, whereas MSC-PK, MSC-PKC and MSC-PKCM cells form three-dimensional colonies. Scale bars indicate 400 μm. ( f ) Upper: H&E-stained section of paucicellular nodule formed by injected MSC-PKC cells. The nodule consists mainly of matrigel with fat islands, capillary sprouts and isolated cells with slightly irregular nuclei. Scale bar indicates 500 μm. The arrow indicates an area of higher cellularity. Lower: Mesenchymal cells with slightly irregular nuclei embedded in a myxoid stroma are evident at higher magnification. Scale bar indicates 100 μm. ( g ) H&E-stained sections of MSC-PKCM derived tumour. This tumour is mostly highly cellular, but a matrix-rich area is still present, for example, as indicated by an asterisk. In the cellular areas, large tumour cells with pleomorphic nuclei are evident. A chronic inflammatory reaction is also present. Scale bar indicates 200 μm.

Article Snippet: Ras activity was analysed using the Ras Activation Assay Kit (Merck, Millipore, Darmstadt, Germany).

Techniques: Transformation Assay, Genetically Modified, Amplification, Activation Assay, Western Blot, Mutagenesis, Inhibition, Cell Culture, Staining, Injection, Isolation, Derivative Assay